Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions
| Status: | Completed |
|---|---|
| Conditions: | Migraine Headaches |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 1/25/2018 |
| Start Date: | September 2007 |
| End Date: | September 2007 |
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Naratriptan Hydrochloride 2.5 mg Tablets Under Fasted Conditions
The objective of this study was to prove the bioequivalence of Naratriptan Hydrochloride
Tablet under fasted conditions.
Tablet under fasted conditions.
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs.
- History of allergic or adverse response to naratriptan hydrochloride or any comparable
or similar product.
We found this trial at
1
site
Click here to add this to my saved trials
